Yulan Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yulan Ren has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Zhihan Chen
School of Acupuncture Moxibustion and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China
5 shared publications Su Zhang
Chengdu Univ Tradit Chinese Med, Sch Acupuncture & Tuina, Chengdu, Peoples R China
4 shared publicationsXin Zhou
Chengdu Univ Tradit Chinese Med, Sch Acupuncture & Tuina, Chengdu, Peoples R China
4 shared publications- Fanrong Liang
Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China
3 shared publications Yiwei Zeng
School of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China
3 shared publications- Yiwei Zeng
School of Acupuncture and Tuina, Chengdu University of Traditional Chinese Medicine, Chengdu, China
3 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by Springer Nature in Journal of Saudi Chemical Society
- Vol. 30 (4) , 57
Electronic structure engineering and photocatalytic potential of MA2N4 two-dimensional materials: a first-principles perspective
- 27 July 2026
- Published by Springer Nature in Journal of Saudi Chemical Society
- Vol. 30 (4) , 57
Open AccessElectronic structure engineering and photocatalytic potential of MA2N4 two-dimensional materials: a first-principles perspective
- 15 June 2026
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- p. 1-15
Temporal trends and future projections of amphetamine use disorder in China and the United States: findings from the Global Burden of Disease Study 2023
Background: Amphetamine use disorder (AUD) is a growing public health concern, yet comparative evidence on long-term trends and future burden in China and the United States remains limited due to differing drug policy and sociocultural contexts.Objectives: To compare sex-specific long-term trends and future burden of AUD in China and the United States.Methods: Data on incidence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2023 were obtained from the Global Burden of Disease 2023 study for males and females. Given known sex differences in substance use burden, analyses were stratified by sex. Joinpoint regression, age - period - cohort (APC) analysis, and autoregressive integrated moving average (ARIMA) models were applied to assess trends and project rates through 2038.Results: Males had consistently higher age-standardized incidence rate (ASIR) and age-standardized disability-adjusted life year rate (ASDR) than females in both countries. In 2023, ASDR among males and females were 51.92 and 30.73 per 100,000 in China, compared with 175.38 and 82.82 per 100,000 in the United States, respectively. China showed significant declining trends in ASIR and ASDR (average annual percent change [AAPC] -1.38% and -1.67%, both p < .05), whereas the United States showed increasing trends (AAPC 1.03% and 4.26%, both p < .05). APC analysis showed declining cohort effects in China but increasing risks among recent U.S. cohorts. Projections suggested continued increases among U.S. males.Conclusions: AUD burden declined in China but increased in the United States. Strengthening prevention and treatment strategies may help reduce future burden.
- 15 June 2026
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- p. 1-15
Temporal trends and future projections of amphetamine use disorder in China and the United States: findings from the Global Burden of Disease Study 2023
Background: Amphetamine use disorder (AUD) is a growing public health concern, yet comparative evidence on long-term trends and future burden in China and the United States remains limited due to differing drug policy and sociocultural contexts.Objectives: To compare sex-specific long-term trends and future burden of AUD in China and the United States.Methods: Data on incidence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2023 were obtained from the Global Burden of Disease 2023 study for males and females. Given known sex differences in substance use burden, analyses were stratified by sex. Joinpoint regression, age - period - cohort (APC) analysis, and autoregressive integrated moving average (ARIMA) models were applied to assess trends and project rates through 2038.Results: Males had consistently higher age-standardized incidence rate (ASIR) and age-standardized disability-adjusted life year rate (ASDR) than females in both countries. In 2023, ASDR among males and females were 51.92 and 30.73 per 100,000 in China, compared with 175.38 and 82.82 per 100,000 in the United States, respectively. China showed significant declining trends in ASIR and ASDR (average annual percent change [AAPC] -1.38% and -1.67%, both p < .05), whereas the United States showed increasing trends (AAPC 1.03% and 4.26%, both p < .05). APC analysis showed declining cohort effects in China but increasing risks among recent U.S. cohorts. Projections suggested continued increases among U.S. males.Conclusions: AUD burden declined in China but increased in the United States. Strengthening prevention and treatment strategies may help reduce future burden.
- Open Access
- 21 January 2026
- Published by Wiley in Addiction Biology
- Vol. 31 (1) , e70127
Association Between Heroin Use and Depression: NHANES 2005–2018
Heroin use and major depression are each leading contributors to global disability and premature mortality, yet evidence for a specific association between the two remains fragmented and is often derived from small, treatment‐seeking samples. We conducted a cross‐sectional analysis of nationally representative data from the 2005–2018 National Health and Nutrition Examination Survey, including 19 022 US adults aged ≥ 20 years with complete information on heroin use, depression status, and relevant covariates. Clinically significant depression was defined as a PHQ‐9 score ≥ 10. After multivariable adjustment for sociodemographic, behavioural, and clinical factors, including polysubstance use and chronic medical conditions, lifetime heroin use was independently associated with depression (adjusted OR = 1.85, 95% CI 1.43–2.40; p < 0.001). Subgroup analyses demonstrated that this association was robust and modified by age and smoking status, with significant interaction effects observed ( p for interaction < 0.05). Restricted cubic spline analysis among participants with a history of heroin use ( n = 439) revealed a non‐linear relationship between age at first heroin use and depression risk ( p for non‐linearity = 0.032), with the highest predicted probability of depression among individuals who initiated use at or before 20.4 years of age. These findings indicate that lifetime heroin use is associated with a substantially increased risk of clinically significant depression in the general US population, particularly among younger adults and current smokers, underscoring the need for integrated screening and concurrent treatment of substance‐use and mood disorders.
- 21 January 2026
- Published by Wiley in Addiction Biology
- Vol. 31 (1) , e70127
Open AccessAssociation Between Heroin Use and Depression: NHANES 2005–2018
Heroin use and major depression are each leading contributors to global disability and premature mortality, yet evidence for a specific association between the two remains fragmented and is often derived from small, treatment‐seeking samples. We conducted a cross‐sectional analysis of nationally representative data from the 2005–2018 National Health and Nutrition Examination Survey, including 19 022 US adults aged ≥ 20 years with complete information on heroin use, depression status, and relevant covariates. Clinically significant depression was defined as a PHQ‐9 score ≥ 10. After multivariable adjustment for sociodemographic, behavioural, and clinical factors, including polysubstance use and chronic medical conditions, lifetime heroin use was independently associated with depression (adjusted OR = 1.85, 95% CI 1.43–2.40; p < 0.001). Subgroup analyses demonstrated that this association was robust and modified by age and smoking status, with significant interaction effects observed ( p for interaction < 0.05). Restricted cubic spline analysis among participants with a history of heroin use ( n = 439) revealed a non‐linear relationship between age at first heroin use and depression risk ( p for non‐linearity = 0.032), with the highest predicted probability of depression among individuals who initiated use at or before 20.4 years of age. These findings indicate that lifetime heroin use is associated with a substantially increased risk of clinically significant depression in the general US population, particularly among younger adults and current smokers, underscoring the need for integrated screening and concurrent treatment of substance‐use and mood disorders.
- 1 January 2025
- Published by World Scientific Publishing House Ltd in Theory and Practice of Science and Technology Science and Technology"
- Vol. 6 (8) , 91-94
Research Report on Red Traditional Chinese Medicine Cultural Resources in Bazhong Area
To deeply explore the connotation of red traditional Chinese medicine (TCM) culture in the core area of the Sichuan-Shaanxi Revolutionary Base, and promote the integrated development of TCM culture inheritance and red cultural resource protection, a systematic investigation was conducted on the red TCM cultural resources in Bazhong area through field visits, cultural relic sorting, and literature analysis. The survey shows that Bazhong area retains rich red TCM cultural relics, including medical books and documents, diagnosis and treatment instruments, and drug specimens, which vividly reflect the important practices of TCM in battlefield medical care, sanitation and epidemic prevention, and talent training during the revolutionary period. The study believes that these resources have important historical value and contemporary significance, and efforts should be made to strengthen publicity and education as well as protection and utilization, so as to provide support for the construction of a strong province in TCM and the inheritance of red culture.
- 1 January 2025
- Published by World Scientific Publishing House Ltd in Theory and Practice of Science and Technology Science and Technology"
- Vol. 6 (8) , 91-94
Research Report on Red Traditional Chinese Medicine Cultural Resources in Bazhong Area
To deeply explore the connotation of red traditional Chinese medicine (TCM) culture in the core area of the Sichuan-Shaanxi Revolutionary Base, and promote the integrated development of TCM culture inheritance and red cultural resource protection, a systematic investigation was conducted on the red TCM cultural resources in Bazhong area through field visits, cultural relic sorting, and literature analysis. The survey shows that Bazhong area retains rich red TCM cultural relics, including medical books and documents, diagnosis and treatment instruments, and drug specimens, which vividly reflect the important practices of TCM in battlefield medical care, sanitation and epidemic prevention, and talent training during the revolutionary period. The study believes that these resources have important historical value and contemporary significance, and efforts should be made to strengthen publicity and education as well as protection and utilization, so as to provide support for the construction of a strong province in TCM and the inheritance of red culture.
- Open Access
- 24 December 2024
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 24 (1) , 424
Efficacy of transcutaneous electrical acupoint stimulation for immunological non-responder in HIV/AIDS combined with amphetamine abuse: study protocol for a randomized controlled trial
BackgroundAmphetamine-type stimulant (ATS) abuse is strongly associated with an elevated risk of HIV infection and transmission. Antiretroviral therapy (ART) serves as the primary approach for managing HIV infection and AIDS progression. However, ATS abuse diminishes the efficacy of ART in HIV/AIDS patients, amplifying the vulnerability to immunological non-response (INR) and ultimately increasing the incidence rate and mortality of opportunistic infections. Currently, no effective interventions targeting INR exist. Acupuncture has demonstrated promise in bidirectionally modulating the body's immune response and may be beneficial for INR in HIV/AIDS combined with ATS abuse. Nevertheless, further research and comprehensive evaluation are imperative to substantiate these findings.MethodsThis study is a two-center, randomized, non-acupoint controlled, single-blind clinical trial. It will be conducted in two large drug rehabilitation centers in western China, involving 114 INR patients receiving ART. The participants will be randomly assigned to either the Transcutaneous Electrical Acupoint Stimulation (TEAS) + ART group or the sham-TEAS + ART group, in a 1:1 ratio. Both groups will receive a 48-week treatment. The primary outcome measure assessed after treatment is the CD4 + T cell count. Secondary outcome measures include the immune reconstitution efficiency of HIV patients, CD4/CD8 ratio, CD4 + CD45RA + and CD4 + CD45RO + counts, CD4 + CD28 + counts, CD4 + CD38 + and CD8 + CD38 + counts, CD4 + ki67 + and CD8 + ki67 + counts, JC mitochondrial membrane potential testing, the incidence of opportunistic infections, and the HIV/AIDS PRO scale. Adverse events occurring during the study observation period will be documented.DiscussionThis study will investigate the effect of TEAS on immune reconstitution in patients with amphetamine abuse and HIV infection.Trial registrationChinese Clinical Trial Registry, ChiCTR 2300076363. Registered on October 7, 2023, https://www.chictr.org.cn/.
- 24 December 2024
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 24 (1) , 424
Open AccessEfficacy of transcutaneous electrical acupoint stimulation for immunological non-responder in HIV/AIDS combined with amphetamine abuse: study protocol for a randomized controlled trial
BackgroundAmphetamine-type stimulant (ATS) abuse is strongly associated with an elevated risk of HIV infection and transmission. Antiretroviral therapy (ART) serves as the primary approach for managing HIV infection and AIDS progression. However, ATS abuse diminishes the efficacy of ART in HIV/AIDS patients, amplifying the vulnerability to immunological non-response (INR) and ultimately increasing the incidence rate and mortality of opportunistic infections. Currently, no effective interventions targeting INR exist. Acupuncture has demonstrated promise in bidirectionally modulating the body's immune response and may be beneficial for INR in HIV/AIDS combined with ATS abuse. Nevertheless, further research and comprehensive evaluation are imperative to substantiate these findings.MethodsThis study is a two-center, randomized, non-acupoint controlled, single-blind clinical trial. It will be conducted in two large drug rehabilitation centers in western China, involving 114 INR patients receiving ART. The participants will be randomly assigned to either the Transcutaneous Electrical Acupoint Stimulation (TEAS) + ART group or the sham-TEAS + ART group, in a 1:1 ratio. Both groups will receive a 48-week treatment. The primary outcome measure assessed after treatment is the CD4 + T cell count. Secondary outcome measures include the immune reconstitution efficiency of HIV patients, CD4/CD8 ratio, CD4 + CD45RA + and CD4 + CD45RO + counts, CD4 + CD28 + counts, CD4 + CD38 + and CD8 + CD38 + counts, CD4 + ki67 + and CD8 + ki67 + counts, JC mitochondrial membrane potential testing, the incidence of opportunistic infections, and the HIV/AIDS PRO scale. Adverse events occurring during the study observation period will be documented.DiscussionThis study will investigate the effect of TEAS on immune reconstitution in patients with amphetamine abuse and HIV infection.Trial registrationChinese Clinical Trial Registry, ChiCTR 2300076363. Registered on October 7, 2023, https://www.chictr.org.cn/.
- Open Access
Acupuncture for angina post percutaneous coronary intervention: a protocol for systematic review and meta-analysis
Introduction Ischaemic heart disease (IHD) is a pathological process characterised by a blockage or non-obstructive accumulation of atherosclerotic plaques in the epicardial arteries. Percutaneous coronary intervention (PCI) is widely used in clinical practice to treat IHD. However, angina post PCI (APPCI) impairs quality of life and portends a worse prognosis. Hence, an effective and safe treatment option remains an urgent need for patients with APPCI. In recent years, there has been an increasing body of clinical trials regarding the use of acupuncture for the prevention and treatment of APPCI, and the results have indicated it might be a promising therapeutic intervention. However, to our knowledge, the potential benefits of acupuncture for the prevention and treatment of APPCI to justify either their recommendation or their clinical role have not been evaluated. Methods and analysis PubMed, Embase, Cochrane Library, Web of Science Core Collection, Chinese Biomedical Database, Chinese National Knowledge Infrastructure, Wanfang Database and VIP Database will be searched from inception to 8 June 2024 without language restrictions. Two investigators will independently screen studies, extract data, assess the risk of bias from randomised controlled trials (RCTs) and assess the risk of bias. The third reviewer will arbitrate any disagreements. Data synthesis and analysis will be conducted using the RevMan V.5.4 software. Subgroup analyses, sensitivity analysis, meta-regression and bias reporting assessments will be performed if necessary and appropriate. Finally, the quality of evidence from RCTs will be assessed using the Grading of Recommendations Assessment, Development, and Evaluation System tool. Ethics and dissemination Ethical approval is unnecessary since no private or confidential patient data will be included. The systematic review will be published in peer-reviewed journals. PROSPERO registration number CRD42024562116.
Open AccessAcupuncture for angina post percutaneous coronary intervention: a protocol for systematic review and meta-analysis
Introduction Ischaemic heart disease (IHD) is a pathological process characterised by a blockage or non-obstructive accumulation of atherosclerotic plaques in the epicardial arteries. Percutaneous coronary intervention (PCI) is widely used in clinical practice to treat IHD. However, angina post PCI (APPCI) impairs quality of life and portends a worse prognosis. Hence, an effective and safe treatment option remains an urgent need for patients with APPCI. In recent years, there has been an increasing body of clinical trials regarding the use of acupuncture for the prevention and treatment of APPCI, and the results have indicated it might be a promising therapeutic intervention. However, to our knowledge, the potential benefits of acupuncture for the prevention and treatment of APPCI to justify either their recommendation or their clinical role have not been evaluated. Methods and analysis PubMed, Embase, Cochrane Library, Web of Science Core Collection, Chinese Biomedical Database, Chinese National Knowledge Infrastructure, Wanfang Database and VIP Database will be searched from inception to 8 June 2024 without language restrictions. Two investigators will independently screen studies, extract data, assess the risk of bias from randomised controlled trials (RCTs) and assess the risk of bias. The third reviewer will arbitrate any disagreements. Data synthesis and analysis will be conducted using the RevMan V.5.4 software. Subgroup analyses, sensitivity analysis, meta-regression and bias reporting assessments will be performed if necessary and appropriate. Finally, the quality of evidence from RCTs will be assessed using the Grading of Recommendations Assessment, Development, and Evaluation System tool. Ethics and dissemination Ethical approval is unnecessary since no private or confidential patient data will be included. The systematic review will be published in peer-reviewed journals. PROSPERO registration number CRD42024562116.
- Open Access
- 18 April 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116629
Construction of preclinical evidence for propofol in the treatment of reperfusion injury after acute myocardial infarction: A systematic review and meta-analysis
- 18 April 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116629
Open AccessConstruction of preclinical evidence for propofol in the treatment of reperfusion injury after acute myocardial infarction: A systematic review and meta-analysis
- Open Access
- 13 July 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1221970
Medical prediction from missing data with max-minus negative regularized dropout
Missing data is a naturally common problem faced in medical research. Imputation is a widely used technique to alleviate this problem. Unfortunately, the inherent uncertainty of imputation would make the model overfit the observed data distribution, which has a negative impact on the model generalization performance. R-Drop is a powerful technique to regularize the training of deep neural networks. However, it fails to differentiate the positive and negative samples, which prevents the model from learning robust representations. To handle this problem, we propose a novel negative regularization enhanced R-Drop scheme to boost performance and generalization ability, particularly in the context of missing data. The negative regularization enhanced R-Drop additionally forces the output distributions of positive and negative samples to be inconsistent with each other. Especially, we design a new max-minus negative sampling technique that uses the maximum in-batch values to minus the mini-batch to yield the negative samples to provide sufficient diversity for the model. We test the resulting max-minus negative regularized dropout method on three real-world medical prediction datasets, including both missing and complete cases, to show the effectiveness of the proposed method.
- 13 July 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1221970
Open AccessMedical prediction from missing data with max-minus negative regularized dropout
Missing data is a naturally common problem faced in medical research. Imputation is a widely used technique to alleviate this problem. Unfortunately, the inherent uncertainty of imputation would make the model overfit the observed data distribution, which has a negative impact on the model generalization performance. R-Drop is a powerful technique to regularize the training of deep neural networks. However, it fails to differentiate the positive and negative samples, which prevents the model from learning robust representations. To handle this problem, we propose a novel negative regularization enhanced R-Drop scheme to boost performance and generalization ability, particularly in the context of missing data. The negative regularization enhanced R-Drop additionally forces the output distributions of positive and negative samples to be inconsistent with each other. Especially, we design a new max-minus negative sampling technique that uses the maximum in-batch values to minus the mini-batch to yield the negative samples to provide sufficient diversity for the model. We test the resulting max-minus negative regularized dropout method on three real-world medical prediction datasets, including both missing and complete cases, to show the effectiveness of the proposed method.
- Open Access
Acupuncture for protracted opioid abstinence syndrome: study protocol for a systematic review and meta-analysis
Introduction Protracted opioid abstinence syndrome (POAS) refers to a series of physical discomforts and neuropsychiatric symptoms after discontinuation of opioid-type substances for a certain amount of time and is one of the main causes of relapse. Studies have shown that acupuncture is effective in the treatment of POAS. We plan to conduct this systematic review and meta-analysis to assess the efficacy and safety of acupuncture for POAS. Methods and analysis A comprehensive search of studies will be carried out in the following databases from inception to 31 January 2023: Web of Science, Embase, PubMed, Chinese Biology Medicine, China National Knowledge Infrastructure, Wan Fang Database and Chinese Scientific Journal Database (VIP). WHO International Clinical Trials Registry Platform, ClinicalTrials.gov and Chinese Clinical Trial Registry will also be searched for ongoing relevant trials, and ‘grey literatures’ will be identified from GreyNet International, OpenGrey and Google Scholar. Randomised controlled trials regarding acupuncture therapy for treatment of POAS will be included. The primary outcome is the severity of protracted withdrawal symptoms. Two reviewers will screen studies using the inclusion criteria, extract data and assess the risk of bias, respectively. The quality of evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluation. Data synthesis will be performed using RevMan V.5.4.1. Ethics and dissemination This study will not invade patients' personal privacy, and so ethical review is not required. The results will be disseminated in a peer-reviewed journal. PROSPERO registration number CRD42022382978.
Open AccessAcupuncture for protracted opioid abstinence syndrome: study protocol for a systematic review and meta-analysis
Introduction Protracted opioid abstinence syndrome (POAS) refers to a series of physical discomforts and neuropsychiatric symptoms after discontinuation of opioid-type substances for a certain amount of time and is one of the main causes of relapse. Studies have shown that acupuncture is effective in the treatment of POAS. We plan to conduct this systematic review and meta-analysis to assess the efficacy and safety of acupuncture for POAS. Methods and analysis A comprehensive search of studies will be carried out in the following databases from inception to 31 January 2023: Web of Science, Embase, PubMed, Chinese Biology Medicine, China National Knowledge Infrastructure, Wan Fang Database and Chinese Scientific Journal Database (VIP). WHO International Clinical Trials Registry Platform, ClinicalTrials.gov and Chinese Clinical Trial Registry will also be searched for ongoing relevant trials, and ‘grey literatures’ will be identified from GreyNet International, OpenGrey and Google Scholar. Randomised controlled trials regarding acupuncture therapy for treatment of POAS will be included. The primary outcome is the severity of protracted withdrawal symptoms. Two reviewers will screen studies using the inclusion criteria, extract data and assess the risk of bias, respectively. The quality of evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluation. Data synthesis will be performed using RevMan V.5.4.1. Ethics and dissemination This study will not invade patients' personal privacy, and so ethical review is not required. The results will be disseminated in a peer-reviewed journal. PROSPERO registration number CRD42022382978.
- Open Access
- 8 June 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1209412
Natural products modulate cell apoptosis: a promising way for treating endometrial cancer
Endometrial cancer (EC) is a prevalent epithelial malignancy in the uterine corpus’s endometrium and myometrium. Regulating apoptosis of endometrial cancer cells has been a promising approach for treating EC. Recent in-vitro and in-vivo studies show that numerous extracts and monomers from natural products have pro-apoptotic properties in EC. Therefore, we have reviewed the current studies regarding natural products in modulating the apoptosis of EC cells and summarized their potential mechanisms. The potential signaling pathways include the mitochondria-dependent apoptotic pathway, endoplasmic reticulum stress (ERS) mediated apoptotic pathway, the mitogen-activated protein kinase (MAPK) mediated apoptotic pathway, NF-κB-mediated apoptotic pathway, PI3K/AKT/mTOR mediated apoptotic pathway, the p21-mediated apoptotic pathway, and other reported pathways. This review focuses on the importance of natural products in treating EC and provides a foundation for developing natural products-based anti-EC agents.
- 8 June 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1209412
Open AccessNatural products modulate cell apoptosis: a promising way for treating endometrial cancer
Endometrial cancer (EC) is a prevalent epithelial malignancy in the uterine corpus’s endometrium and myometrium. Regulating apoptosis of endometrial cancer cells has been a promising approach for treating EC. Recent in-vitro and in-vivo studies show that numerous extracts and monomers from natural products have pro-apoptotic properties in EC. Therefore, we have reviewed the current studies regarding natural products in modulating the apoptosis of EC cells and summarized their potential mechanisms. The potential signaling pathways include the mitochondria-dependent apoptotic pathway, endoplasmic reticulum stress (ERS) mediated apoptotic pathway, the mitogen-activated protein kinase (MAPK) mediated apoptotic pathway, NF-κB-mediated apoptotic pathway, PI3K/AKT/mTOR mediated apoptotic pathway, the p21-mediated apoptotic pathway, and other reported pathways. This review focuses on the importance of natural products in treating EC and provides a foundation for developing natural products-based anti-EC agents.